当前位置: X-MOL 学术Polym. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Advancing the stimuli response of polymer-based drug delivery systems for ocular disease treatment
Polymer Chemistry ( IF 4.1 ) Pub Date : 2020-09-25 , DOI: 10.1039/d0py00919a
Duc Dung Nguyen 1, 2, 3, 4 , Jui-Yang Lai 1, 2, 3, 4, 5
Affiliation  

The development of efficient therapies for ocular diseases remains a significant challenge because of the static and dynamic barriers in the eye. A variety of pharmaceutical strategies have been explored to overcome these ocular physiological barriers and thereby improve therapeutic bioavailability in both anterior and posterior ocular tissues. This mini-review summarizes, analyzes, and discusses recent advances in the field of ophthalmic drug delivery systems (DDSs). Specifically, the focus is on design strategies using stimuli-responsive polymers and their applications for the treatment of prevalent ocular diseases such as dry eye, ocular infection, glaucoma, and age-related macular degeneration. The stimuli-responsive polymers are categorized according to their responses in various ocular environmental conditions (such as temperature, pH, and ions). Additionally, general strategies and methodologies for the construction of effective ophthalmic stimuli-responsive DDSs are investigated by exploiting key parameters such as the stimuli-response type, ocular biocompatibility, ocular biodegradability, drug encapsulation and release, as well as the modifiable structure of the polymers. Also discussed in this review are the interrelationships among the designed structures, properties, and functions of the stimuli-responsive DDSs and their pharmacological treatment efficacies. In summary, we believe that the recent progress in the field of stimuli-responsive DDSs constitutes a significant advance for the development of effective pharmacological treatments for eye disorders.

中文翻译:

推进基于聚合物的药物输送系统对眼病治疗的刺激反应

由于眼中的静态和动态屏障,针对眼部疾病的有效疗法的发展仍然是一项重大挑战。已经探索了多种药物策略来克服这些眼生理障碍,从而改善前眼组织和后眼组织的治疗生物利用度。这份小型回顾总结,分析和讨论了眼科药物输送系统(DDS)领域的最新进展。具体而言,重点是使用刺激响应性聚合物的设计策略及其在治疗常见眼病(如干眼症,眼部感染,青光眼和年龄相关性黄斑变性)中的应用。刺激响应聚合物根据其在各种眼部环境条件(例如温度,pH,和离子)。另外,通过利用关键参数,例如刺激反应类型,眼生物相容性,眼生物降解性,药物包封和释放以及聚合物的可修饰结构,研究了构建有效的眼刺激反应性DDS的一般策略和方法。 。在这篇综述中还讨论了刺激反应性DDS的设计结构,性质和功能之间的相互关系及其药理治疗效果。总而言之,我们认为,在刺激反应性DDSs领域中的最新进展为开发针对眼部疾病的有效药理疗法取得了重大进展。通过利用诸如刺激反应类型,眼生物相容性,眼生物可降解性,药物包封和释放以及聚合物的可修饰结构等关键参数,研究了构建有效的眼刺激反应性DDS的一般策略和方法。在这篇综述中还讨论了刺激反应性DDS的设计结构,性质和功能之间的相互关系及其药理治疗效果。总而言之,我们认为,在刺激反应性DDSs领域中的最新进展为开发针对眼部疾病的有效药理疗法取得了重大进展。通过利用诸如刺激反应类型,眼生物相容性,眼生物可降解性,药物包封和释放以及聚合物的可修饰结构等关键参数,研究了构建有效的眼刺激反应性DDS的一般策略和方法。在这篇综述中还讨论了刺激反应性DDS的设计结构,性质和功能之间的相互关系及其药理治疗效果。总而言之,我们认为,在刺激反应性DDSs领域中的最新进展为开发针对眼部疾病的有效药理疗法取得了重大进展。药物的封装和释放,以及聚合物的可修饰结构。在这篇综述中还讨论了刺激反应性DDS的设计结构,性质和功能之间的相互关系及其药理治疗效果。总而言之,我们认为,在刺激反应性DDSs领域中的最新进展为开发针对眼部疾病的有效药理疗法取得了重大进展。药物的封装和释放,以及聚合物的可修饰结构。在这篇综述中还讨论了刺激反应性DDS的设计结构,性质和功能之间的相互关系及其药理治疗效果。总而言之,我们认为,在刺激反应性DDSs领域中的最新进展为开发针对眼部疾病的有效药理学方法取得了重大进展。
更新日期:2020-11-03
down
wechat
bug